Opiant Pharmaceuticals, Inc. is a specialty pharmaceutical company developing therapies to treat substance use disorders and drug overdose.

Addiction isnot a character flaw – it is now recognized as a chronic brain disease with the potential for both recovery and relapse, and we must treat it with the same skill and compassion with which we approach heart disease, diabetes, and cancer (2016 Surgeon General’s Report). It is the most severe manifestation of a substance use disorder (SUD), characterized by significant impairments in health, social function and control over substance use.  Similar to other chronic brain diseases, addiction can and should be treated with medications alongside supportive therapy when appropriate.

In response to this growing public health crisis, Opiant is developing a robust clinical pipeline of products to treat substance use disorders and drug overdose.

Watch CEO Roger Crystal Testifying Before the President’s Commission